Biden's performance criticized, questions raised over decision to prioritize race for COVID drugs

NEWYou can now listen to Fox News articles!

THE VILLAGES, Fla. – Some Americans questioned recent guidance the Biden administration issued stating that race or ethnicity could place patients at high risk of severe COVID-19 infection and more quickly qualify them for monoclonal antibodies and oral antiviral medications

“We’re all in it, the virus is a virus, and you can get it no matter what you are,” Ben told Fox News. 

President Biden in a recent photo. (AP Photo/Evan Vucci, File)

WATCH THE FULL STORY HERE:

Dave, a Democrat from Massachusetts, said he thinks medicine should be available for everyone.

“I don’t see why race is always mentioned nowadays,” Dave said. “You walk into a clinic, you should get taken care of. Whether you’re Black, White, Indian, Japanese, whatever your nationality is, it shouldn’t matter.”

BIDEN ADMINISTRATION GUIDANCE PRIORITIZES RACE IN ADMINISTERING COVID DRUGS

The Food and Drug Administration approved emergency use authorizations of sotrovimab – a monoclonal antibody proven to be effective against the omicron variant – only to patients considered “high risk,” according to a fact sheet the agency released.

FDA sign at its headquarters in Washington.

The guidance, updated in December 2021, said “medical conditions or factors” such as

View Source